25.55 USD
↗ 0.21 (0.83%)AT CLOSE (03:59 PM EDT)
Nurix Therapeutics, Inc. Common stock
NRIXNASDAQ • USD
25.02
↘ 0.53 (2.07%)
POST MARKET (AS OF 07:44 PM EDT)
Post Market
AS OF 07:44 PM EDT
25.02
↘ 0.53 (2.07%)
Market: CLOSED
NRIX is currently priced at $25.55. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, exceptional Return on Equity (30.4%) and a bullish Golden Cross on the moving averages. On the valuation side, NRIX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$25.35
High?$25.82
Low?$25.03
Prev. Close?$25.34
Volume?2.3M
Avg. Volume?2.2M
VWAP?$25.47
Rel. Volume?1.07x
Bid / Ask
Bid?$20.45 × 100
Ask?$29.94 × 100
Spread?$9.49
Midpoint?$25.20
Valuation & Ratios
Market Cap?2.8B
Shares Out?109.2M
Float?98.2M
Float %?94.6%
P/E Ratio?9.39
P/B Ratio?2.86
EPS?$2.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Themes
Address
1600 SIERRA POINT PKWY
BRISBANE, CA 94005
Phone: (415) 660-5320
BRISBANE, CA 94005
Phone: (415) 660-5320
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?85
Short Sent.?15
Piotroski F-Score?4/9Mixed
Altman Z-Score?8.94Safe
Confidence?55%Low
Short InterestSqueeze Risk
Short % of Float?20.99%Squeeze Risk
Short Interest?20.6M
Days to Cover?9.2
Free Float98.2M
Avg Daily Volume2.2M
Settlement Date2026-10-15
Financial Health
Current Ratio?8.44Strong
Quick Ratio?8.44Strong
Cash Ratio?5.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score94/100
P/E?9.4CHEAP▾
Peers100
S&P97
P/B?2.86CHEAP▾
Peers100
S&P58
P/S?3.94FAIR▾
Peers100
S&P39
P/FCF?7.5CHEAP▾
Peers100
S&P94
EV/EBITDA?6.9CHEAP▾
Peers100
S&P94
EV/Sales?2.92CHEAP▾
Peers100
S&P62
Returns & Efficiency
ROE?30.5%STRONG▾
Peers50
S&P79
ROA?24.7%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$369.8M
Enterprise Value?$2.0B
Fundamentals ratios updated end of day